Triad3A attenuates pathological cardiac hypertrophy involving the augmentation of ubiquitination-mediated degradation of TLR4 and TLR9.
Lu X, He Y, Tang C, Wang X, Que L, Zhu G, Liu L, Ha T, Chen Q, Li C, et al. Basic Res Cardiol. 2020 Feb 1; 115(2):19. Epub 2020 Feb 1.